Merxin Ltd and OECHSLERhealth are excited to announce a Strategic Partnership to Establish The SMI Powerhouse to Streamline Soft Mist Inhaler Access for Drug Developers.
Through The SMI Powerhouse, Merxin Ltd and OECHSLERhealth will empower inhaled drug developers with faster access to market-ready SMI devices by addressing key enablers. The Strategic Partnership is designed to:
REDUCE TIME TO MARKET
ENHANCE RELIABILITY
WIDEN ACCESS TO SUPERIOR DRUG DELIVERY
OPTIMISE COSTS
We Make Inhalers. We design and supply dry powder and soft mist inhalers for clinical evaluation through to commercial supply. Our expertise encompasses various therapeutic categories, from biologics and small molecules to generic and novel therapies. We work closely with our customers to provide inhaler devices tailored for their drug formulations, ensuring effective final dosage forms for users and patients. Our DNA is in the pharma industry. Merxin Ltd is committed to delivering quality, reliability, and efficacy, our reputation is built on excellence; We Will Launch You. As experts in oral inhaled delivery, we are committed to advancing respiratory healthcare. We Make It Better.
For more information visit:
www.merxin.comand follow us on LinkedIn:
www.linkedin.com/company/merxin-ltdFor more information, contact:
info@merxin.comOECHSLERhealth is the dedicated healthcare business unit of OECHSLER Group, a leader in advanced plastics technology, delivering high-quality manufacturing and development services for medical devices and healthcare solutions worldwide. With more than 30 years of expertise spanning from design to series production and ISO-certified quality management, OECHSLERhealth manufactures medical and pharmaceutical devices for their clients.
For more information visit:
www.oechsler-health.comand follow us on LinkedIn:
www.linkedin.com/showcase/oechsler-healthFor more information, contact:
info@oechsler.com